Home / Health / At-Home Cervical Cancer Tests to Launch Next Year for Unscreened Women

At-Home Cervical Cancer Tests to Launch Next Year for Unscreened Women

Summary

  • At-home kits for cervical cancer screening to be offered starting next year
  • Opportunistic offers in primary care boost uptake of self-sampling kits
  • Over 5 million women in the UK not up to date with routine cervical screenings

In a move to improve cervical cancer screening rates, the UK will begin offering at-home testing kits to women who have rarely or never attended their routine check-ups. Starting next year, these self-sampling kits will test for the human papillomavirus (HPV), the virus linked to the majority of cervical cancer cases.

A recent study conducted across 13 GP surgeries in west London examined the most effective ways to encourage women to use the self-sampling kits. The researchers found that opportunistically offering the kits to women during primary care visits led to the highest uptake, with 74% of the 449 women accepting the offer. In contrast, only 12% of the 1,616 women who were sent a kit in the mail returned a sample, and just 5% of the 1,587 women invited by letter to order a kit followed through.

While the opportunistic approach proved most successful, the researchers noted that a significant number of women who accepted the offer still did not return their sample. They suggest that text or phone reminders could help boost the return rate. Currently, over 5 million women in the UK are not up to date with their regular cervical screenings, often citing a lack of time, discomfort, or embarrassment as barriers.

The new at-home testing initiative aims to make the process more accessible and comfortable for women, ultimately helping to improve cervical cancer detection and prevention across the country.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

The new at-home tests look for the human papillomavirus (HPV), which is linked to the majority of cervical cancer cases.
According to the study, opportunistically offering the self-sampling kits to women during GP visits led to a 74% uptake rate, much higher than the 12% and 5% rates when the kits were sent by mail or women were invited to order them.
Many women cite a lack of time, discomfort, or embarrassment as barriers to attending their routine cervical screenings.

Read more news on